Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies

We aimed to calculate the value-based price of each indication and compare the drug price and budget impact among value-based pricing (VBP) scenarios, using immunotherapy as a case. Atezolizumab, nivolumab, and pembrolizumab prices were estimated for VBP scenarios, namely indication value-based pric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, So-Young, Kang, Dong-Won, Jung, Hye-In, Lee, Eui-Kyung, Park, Mi-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998444/
https://www.ncbi.nlm.nih.gov/pubmed/35409788
http://dx.doi.org/10.3390/ijerph19074105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998444/
https://www.ncbi.nlm.nih.gov/pubmed/35409788
http://dx.doi.org/10.3390/ijerph19074105

Ejemplares similares